Table 1 Demographic details of PanNET patients.
From: C1QA and COMP: plasma-based biomarkers for early diagnosis of pancreatic neuroendocrine tumors
Characteristics | No. of patients (n = 28) | Percentage % | |
|---|---|---|---|
Age in years | Mean ± SEM | 41.89 ± 2.75 (20–70) | |
20–50 | 21 | 75% | |
Above 50 | 07 | 25% | |
Sex | Male | 15 | 53.5% |
Female | 13 | 46.4% | |
Metastasis | 13 | 46.4% | |
Stage/Grade | Grade I PanNET | 14 | 50% |
Grade II PanNET | 14 | 50% | |
Grade III PanNET | - | – | |
Ki67 index | 1–2% | 14 | 50% |
3–5% | 11 | 39.28% | |
> 5% | 03 | 10.71% | |
